MAXCYTE INC's ticker is and the CUSIP is 57777K106. A total of 116 filers reported holding MAXCYTE INC in Q2 2023. The put-call ratio across all filers is 4.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $98 | -38.4% | 31,565 | -9.6% | 0.00% | – |
| Q2 2023 | $159 | -58.8% | 34,924 | -55.2% | 0.00% | – |
| Q1 2023 | $386 | +132.5% | 77,878 | +154.5% | 0.00% | – |
| Q4 2022 | $166 | -99.8% | 30,597 | +172.7% | 0.00% | – |
| Q3 2022 | $72,000 | +18.0% | 11,220 | -12.3% | 0.00% | – |
| Q2 2022 | $61,000 | -73.8% | 12,792 | -61.5% | 0.00% | – |
| Q1 2022 | $233,000 | +870.8% | 33,229 | +1296.2% | 0.00% | – |
| Q4 2021 | $24,000 | +60.0% | 2,380 | +95.2% | 0.00% | – |
| Q3 2021 | $15,000 | – | 1,219 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 3,225,000 | $17,608,500 | 11.83% |
| Vitruvian Partners LLP | 5,043,356 | $27,536,724 | 5.80% |
| NORTH RUN CAPITAL, LP | 451,960 | $2,467,702 | 5.67% |
| Casdin Capital, LLC | 9,505,000 | $51,897,300 | 4.02% |
| RIVER GLOBAL INVESTORS LLP | 1,648,238 | $8,749 | 1.88% |
| Pier Capital, LLC | 1,074,164 | $5,864,935 | 0.96% |
| Montanaro Asset Management Ltd | 929,000 | $4,915,460 | 0.80% |
| First Light Asset Management, LLC | 1,365,343 | $7,454,773 | 0.69% |
| Stonepine Capital Management, LLC | 273,287 | $1,492,147 | 0.63% |
| Mudita Advisors LLP | 90,201 | $492,498 | 0.43% |